Navigation Links
Renal Transplantation in Children Younger Than 6 Years Old

Garcia, et al reported their experience with renal transplantation in 38 children //(40 transplant), ages 1-5 years over a 16 year period. Demographics as well as patient and graft survivals were all reported. The mean age at transplantation was 3.3 ± 1.3 years and the mean weight was 14 kilograms with a range of 5.7-25 kg. The population consisted of 92.5% Caucasian, 7.5% African Brazilian. The main etiology for end-stage renal disease was uropathic/vesicoureteral reflux in 45% of the children followed by glomerulopathy in 25%, congenital/hereditary disease in 10% and hemolytic uremic syndrome at 12.5%. Prior to transplantation, 5% were on hemodialysis, 85% on peritoneal dialysis, and 10% were preemptive transplants.

All the children were followed for at least 6 months posttransplantation, except 2 who died in the first month. In 75% of the cases, kidneys were obtained from living-related donors, an in 25% they were cadaveric. Thirty-nine kidneys were placed extraperitoneal. The primary immunosuppressant therapy consisted of cyclosporine in 61% of the patients, tacrolimus in 39%, mycophenolate in 49% and azathioprine in 51%. A steroid-free protocol was used in 17% of the patients. In the last 21 cases, basiliximab or daclizumab was added.

The group found that there were 13 (32.5%) graft losses. Four of these had artery/vein thromboses, 3 chronic rejections, 3 deaths, and 3 were other causes. The 5-year patient and graft survival rates were 89.6% and 72.2%, respectively. With this information, the group concluded that renal transplantation can be performed with good long term results in children younger than 6 years of age.

Source-Newswise/N
'"/>




Page: 1

Related medicine news :

1. Renal problem alleviated
2. Effect of drug on Renal Cancer
3. Renal problem increased
4. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
5. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
6. A Novel Method Of Detection Of High Nuclear Grade Localized Renal Cell Carcinoma
7. Negative Impact Of Hepatitis C Infection In Renal Transplant Recipients
8. Clinical Renal Trails Do Not Have Sufficient Women Participants
9. Sunitinib a Promising Agent for Treatment of Renal Cell Cancer
10. New Biotech Drugs to Aid in Renal Cell Carcinoma Treatment
11. MRI Contrast Agent Linked to Complication in Renal Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: